Astera Labs (ALAB) Cash & Equivalents (2023 - 2026)

Astera Labs (ALAB) has reported Cash & Equivalents for 4 consecutive years, with $148.3 million the latest figure, recorded in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $148.3 million, up 71.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $148.3 million (up 71.56% YoY), and the FY2025 annual result was $167.6 million, up 110.7% from the prior year.
• Cash & Equivalents was $148.3 million for Q1 2026 at Astera Labs, down from $167.6 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $696.1 million in Q1 2024 and troughed at $45.1 million in Q4 2023.
• Average Cash & Equivalents over 4 years is $207.3 million, with a median of $144.3 million recorded in 2025.
• The widest YoY moves for Cash & Equivalents: up 110.7% in 2025, down 87.58% in 2025.
• Over 4 years, Cash & Equivalents stood at $45.1 million in 2023, then jumped by 76.4% to $79.6 million in 2024, then surged by 110.7% to $167.6 million in 2025, then slipped by 11.53% to $148.3 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $148.3 million in Q1 2026, $167.6 million in Q4 2025, and $140.4 million in Q3 2025.